(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide
C122H143ClF3N25O13S2 — CID 159959701
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide
(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide (PubChem CID 159959701) has the molecular formula C122H143ClF3N25O13S2 and a molecular weight of 2324.23 g/mol. Its IUPAC name is (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide.
Molecular Properties
| Compound Name | (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide |
|---|---|
| PubChem CID | 159959701 |
| Molecular Formula | C122H143ClF3N25O13S2 |
| Molecular Weight | 2324.23 g/mol |
| Exact Mass | 2322.04 |
| IUPAC Name | (3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-(furan-2-yl)-3-hydroxybutanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-(1,3-thiazol-2-yl)butanamide;(3S)-N-(3-tert-butyl-5-methylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-thiophen-2-ylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide;(3S)-N-[3-cyclobutyl-6-cyclopropyl-5-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-3-hydroxy-3-phenylbutanamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-hydroxy-3-phenylpentanamide |
| SMILES | CCC(O)(CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1)c1ccccc1.CCC(O)(CC(=O)Nc1nc2cccnc2n1C1CCC1)c1ccccc1.C[C@](O)(CC(=O)Nc1nc2cc(C3CC3)c(C(F)(F)F)nc2n1C1CCC1)c1ccccc1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3ccco3)n(C(C)(C)C)c2n1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3cccs3)n(C(C)(C)C)c2n1.Cc1ccc2nc(NC(=O)C[C@](C)(O)c3nccs3)n(C(C)(C)C)c2n1 |
| InChI | InChI=1S/C24H25F3N4O2.C21H23ClN4O2.C21H24N4O2.C19H24N4O3.C19H24N4O2S.C18H23N5O2S/c1-23(33,15-6-3-2-4-7-15)13-19(32)29-22-28-18-12-17(14-10-11-14)20(24(25,26)27)30-21(18)31(22)16-8-5-9-16;1-2-21(28,14-7-4-3-5-8-14)13-18(27)25-20-23-16-11-12-17(22)24-19(16)26(20)15-9-6-10-15;1-2-21(27,15-8-4-3-5-9-15)14-18(26)24-20-23-17-12-7-13-22-19(17)25(20)16-10-6-11-16;2*1-12-8-9-13-16(20-12)23(18(2,3)4)17(21-13)22-15(24)11-19(5,25)14-7-6-10-26-14;1-11-6-7-12-14(20-11)23(17(2,3)4)16(21-12)22-13(24)10-18(5,25)15-19-8-9-26-15/h2-4,6-7,12,14,16,33H,5,8-11,13H2,1H3,(H,28,29,32);3-5,7-8,11-12,15,28H,2,6,9-10,13H2,1H3,(H,23,25,27);3-5,7-9,12-13,16,27H,2,6,10-11,14H2,1H3,(H,23,24,26);2*6-10,25H,11H2,1-5H3,(H,21,22,24);6-9,25H,10H2,1-5H3,(H,21,22,24)/t23-;;;2*19-;18-/m0..000/s1 |
| InChIKey | ODEBTZZKISVFCX-YXFFTVEUSA-N |
| XLogP | 23.81 |
| TPSA | 506.27 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 166 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2324.23 |
| LogP ≤ 5 | 23.81 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 34 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159959701 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.